Related Experiment Video
Updated: Jun 5, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
Histidine‑rich Glycoprotein Modulates Platelet Adhesion and Aggregation by Binding to GPIbα and GPIIb/IIIa
Rida Malik1, Ji Zhou2, Miguel A D Neves3
1McMaster University | Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
Histidine-rich glycoprotein (HRG) regulates platelet function by binding to key receptors, inhibiting adhesion and aggregation. Lower HRG levels in sepsis and COVID-19 patients correlate with hyperreactive platelets.
Area of Science:
- Hematology
- Biochemistry
- Molecular Biology
Background:
- Histidine-rich glycoprotein (HRG) is a plasma protein known to modulate the contact system.
- HRG's role in platelet biology, despite its presence on platelet surfaces, was previously unclear.
- Understanding HRG's interaction with platelet receptors is crucial for elucidating its function in hemostasis and thrombosis.
Purpose of the Study:
- To investigate the direct engagement of HRG with platelet receptors.
- To determine HRG's effect on platelet adhesion, aggregation, and thrombus formation.
- To explore the clinical relevance of HRG levels in inflammatory conditions.
Main Methods:
- Utilized human and murine platelets for in vitro experiments.
- Employed binding assays to assess HRG interaction with glycoprotein (GP)Ibα and GPIIb/IIIa.
- Performed flow-based assays and microperfusion chambers to evaluate platelet function under shear stress.
- Analyzed plasma HRG levels in patients with sepsis and COVID-19.
Main Results:
- HRG binds to GPIbα on resting and activated platelets and to GPIIb/IIIa on activated platelets.
- HRG competitively inhibits von Willebrand factor (VWF) and fibrinogen binding to their respective platelet receptors.
- HRG attenuates platelet agglutination, aggregation, VWF-mediated platelet string formation, and thrombus growth under high shear.
- Reduced plasma HRG levels in sepsis and COVID-19 patients were associated with a hyperreactive platelet phenotype in vitro.
Conclusions:
- HRG directly modulates platelet adhesion and aggregation by interacting with GPIbα and GPIIb/IIIa.
- HRG acts as an endogenous inhibitor of platelet activation, competing with VWF and fibrinogen.
- HRG deficiency contributes to platelet hyperreactivity, suggesting a role in thrombotic complications of sepsis and COVID-19.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
GPI Anchoring of Proteins in the ER Membrane
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...

